PIM Experience & Future Strategy: Regulatory and Industry Perspectives

WEBINAR HIGHLIGHTS
• Regulatory Perspective:
o The EMEA and MS business case
o Practical experience—and implementation feedback
o Best practice recommendations for successful PIM assessment
o Opportunities for submitting PIM—guidance on involvement
o Future plans
• Industry Perspective:
o GlaxoSmithKline business case
o Meeting the PIM standard
o PIM and our business process
o Case studies
o Future plans.

NILMINI MURRELL
Global Core Labeling Management (GCLM)
GlaxoSmithKline R&D Learning.